Call For More Information (410) Skype715-2111
Blog: Recent Posts
  1. Microarray Testing- The Benefits vs. The Risks

    Clinical Trial Is Favorable for a Prenatal Gene Test By ANDREW POLLACK A new method of prenatal testing that can detect more genetic problems in a fetus than ever before could be headed toward wider use after encouraging results from a clinical trial, researchers said. The study, which is expected...
  2. Does Responsibility Begin at Conception?

    Responsibility Begins at Conception By SHARI MOTRO Published: July 6, 2012 For most of human history, a woman who became pregnant after sleeping with more than one partner had no way of definitively knowing the identity of the man with whom she had conceived. Likewise, a man whose lover became...

How’s it done?

Ravgen’s core technology is based on its ability to increase the percentage of fetal DNA that is found in the mother’s blood. Through its research with free floating fetal DNA, the company has developed and patented a variety of noninvasive prenatal tests that simply require a safe blood draw from the mother. Currently, the focus for Ravgen’s core technology is on testing for single gene disorders, such as cystic fibrosis, sickle cell anemia, and the Jewish panel, as well as prenatal paternity testing. To complete our Prenatal DNA Paternity test, we require a safe blood draw from the mother’s arm to match the baby’s DNA with a father’s DNA. We can conduct the paternity test after the 8th week of pregnancy with over 99% accuracy. Please contact Ravgen at (410) 715-2111 to make convenient arrangements.